Olga Bessmertny

504 total citations
17 papers, 364 citations indexed

About

Olga Bessmertny is a scholar working on Hematology, Pediatrics, Perinatology and Child Health and Pharmacology. According to data from OpenAlex, Olga Bessmertny has authored 17 papers receiving a total of 364 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Hematology, 6 papers in Pediatrics, Perinatology and Child Health and 5 papers in Pharmacology. Recurrent topics in Olga Bessmertny's work include Hematopoietic Stem Cell Transplantation (6 papers), Drug-Induced Adverse Reactions (4 papers) and Pharmacovigilance and Adverse Drug Reactions (3 papers). Olga Bessmertny is often cited by papers focused on Hematopoietic Stem Cell Transplantation (6 papers), Drug-Induced Adverse Reactions (4 papers) and Pharmacovigilance and Adverse Drug Reactions (3 papers). Olga Bessmertny collaborates with scholars based in United States. Olga Bessmertny's co-authors include Mitchell S. Cairo, Regino P. González‐Peralta, Randy C. Hatton, James H. Garvin, Carmella van de Ven, M.B. Bradley, K. Wolownik, G. Del Toro, Donna Skerrett and Lauren Harrison and has published in prestigious journals such as Journal of Clinical Oncology, British Journal of Haematology and Annals of Emergency Medicine.

In The Last Decade

Olga Bessmertny

17 papers receiving 357 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Olga Bessmertny United States 10 155 87 85 59 55 17 364
Neil Lyman United States 10 76 0.5× 85 1.0× 52 0.6× 7 0.1× 40 0.7× 11 385
Christopher Clardy United States 10 43 0.3× 42 0.5× 54 0.6× 20 0.3× 46 0.8× 17 405
Jesús Montoliu Spain 10 232 1.5× 134 1.5× 48 0.6× 11 0.2× 99 1.8× 13 499
M Tasso Spain 11 144 0.9× 27 0.3× 103 1.2× 11 0.2× 87 1.6× 23 423
Patrícia Nessralla Alpoim Brazil 16 123 0.8× 26 0.3× 258 3.0× 14 0.2× 69 1.3× 37 664
Diana Perkinson United States 5 42 0.3× 70 0.8× 17 0.2× 55 0.9× 12 0.2× 7 405
Y Kadotani Japan 10 48 0.3× 114 1.3× 12 0.1× 31 0.5× 47 0.9× 35 345
Gisella Vischini Italy 10 45 0.3× 53 0.6× 33 0.4× 8 0.1× 36 0.7× 36 379
Kimberly Dinh United States 8 43 0.3× 70 0.8× 42 0.5× 30 0.5× 142 2.6× 15 343
Rajan Kapoor India 11 158 1.0× 35 0.4× 37 0.4× 11 0.2× 44 0.8× 76 360

Countries citing papers authored by Olga Bessmertny

Since Specialization
Citations

This map shows the geographic impact of Olga Bessmertny's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Olga Bessmertny with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Olga Bessmertny more than expected).

Fields of papers citing papers by Olga Bessmertny

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Olga Bessmertny. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Olga Bessmertny. The network helps show where Olga Bessmertny may publish in the future.

Co-authorship network of co-authors of Olga Bessmertny

This figure shows the co-authorship network connecting the top 25 collaborators of Olga Bessmertny. A scholar is included among the top collaborators of Olga Bessmertny based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Olga Bessmertny. Olga Bessmertny is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Bessmertny, Olga, et al.. (2005). Rasburicase: A New Approach for Preventing and/or Treating Tumor Lysis Syndrome. Current Pharmaceutical Design. 11(32). 4177–4185. 31 indexed citations
2.
Solari, Sandra, et al.. (2005). Rifampicin Can Alter Pharmacokinetics Of Busulfan in Patients Given Bone Marrow Transplantation. Therapeutic Drug Monitoring. 27(2). 254–254. 1 indexed citations
3.
4.
Osunkwo, Ifeyinwa, Olga Bessmertny, Lauren Harrison, et al.. (2004). A pilot study of tacrolimus and mycophenolate mofetil graft-versus-host disease prophylaxis in childhood and adolescent allogeneic stem cell transplant recipients. Biology of Blood and Marrow Transplantation. 10(4). 246–258. 83 indexed citations
5.
Toro, G. Del, Prakash Satwani, Lauren Harrison, et al.. (2004). A pilot study of reduced intensity conditioning and allogeneic stem cell transplantation from unrelated cord blood and matched family donors in children and adolescent recipients. Bone Marrow Transplantation. 33(6). 613–622. 56 indexed citations
6.
Sulis, Maria Luisa, Olga Bessmertny, Linda Granowetter, Michael A. Weiner, & Kara M. Kelly. (2004). Veno-occlusive disease in pediatric patients receiving actinomycin D and vincristine only for the treatment of rhabdomyosarcoma.. PubMed. 26(12). 843–6. 24 indexed citations
7.
8.
Angiolillo, Anne, Mark Krailo, J Laver, et al.. (2004). A comparison of rhTPO and rhIL-11 following ifosfamide (I), carboplatin (C) and etoposide (E) (ICE) in pediatric patients with recurrent solid tumors or lymphoma. Journal of Clinical Oncology. 22(14_suppl). 8535–8535. 1 indexed citations
9.
Garvin, James H., et al.. (2003). Periostitis secondary to interleukin-11 (Oprelvekin, Neumega). Pediatric Radiology. 33(7). 450–452. 9 indexed citations
10.
Tichy, Eric M., et al.. (2003). A Case of Severe Thrombocytopenia and Antiepileptic Hypersensitivity Syndrome. The Journal of Pediatric Pharmacology and Therapeutics. 8(1). 29–33. 4 indexed citations
11.
12.
Satwani, Prakash, Olga Bessmertny, Erin Morris, & Mitchell S. Cairo. (2003). Prophylactic use of myelopoietic growth factors in children after myelosuppressive and myeloablative therapy.. PubMed. 2(6). 480–90. 1 indexed citations
13.
Bessmertny, Olga, et al.. (2002). A randomized clinical trial of nebulized magnesium sulfate in addition to albuterol in the treatment of acute mild-to-moderate asthma exacerbations in adults. Annals of Emergency Medicine. 39(6). 585–591. 46 indexed citations
14.
Bessmertny, Olga, et al.. (2002). Antiepileptic hypersensitivity syndrome: Clinicians beware and be aware. Current Allergy and Asthma Reports. 2(1). 34–39. 23 indexed citations
15.
Bessmertny, Olga & Trinh Pham. (2002). Thalidomide Use in Pediatric Patients. Annals of Pharmacotherapy. 36(3). 521–525. 11 indexed citations
16.
Bessmertny, Olga, Randy C. Hatton, & Regino P. González‐Peralta. (2001). Antiepileptic Hypersensitivity Syndrome in Children. Annals of Pharmacotherapy. 35(5). 533–538. 46 indexed citations
17.
Bessmertny, Olga, Randy C. Hatton, & Regino P. González‐Peralta. (2001). Antiepileptic Hypersensitivity Syndrome in Children. Annals of Pharmacotherapy. 35. 533–538. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Neil Lyman Breakdown of academic impact, for papers by Christopher Clardy Breakdown of academic impact, for papers by Jesús Montoliu Breakdown of academic impact, for papers by M Tasso Breakdown of academic impact, for papers by Patrícia Nessralla Alpoim Breakdown of academic impact, for papers by Diana Perkinson Breakdown of academic impact, for papers by Y Kadotani Breakdown of academic impact, for papers by Gisella Vischini Breakdown of academic impact, for papers by Kimberly Dinh Breakdown of academic impact, for papers by Rajan Kapoor
Rankless by CCL
2026